EMA — authorised 21 October 2014
- Status: approved
🇪🇺 Imbruvica in European Union
EMA authorised Imbruvica on 21 October 2014
Marketing authorisation
Imbruvica in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Imbruvica approved in European Union?
Yes. EMA authorised it on 21 October 2014.
Who is the marketing authorisation holder for Imbruvica in European Union?
AbbVie is the originator. The local marketing authorisation holder may differ — check the official source linked above.